By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Thursday, December 17th. Please refresh for updates.
Alphabet (NASDAQ:GOOGL) stock rose 0.3% despite ten U.S. states bringing a lawsuit against Google, accusing the search giant of “anti-competitive conduct" in the online advertising industry.
Moderna (NASDAQ:MRNA) stock rose 1.1% ahead of a key FDA panel voting on whether to recommend the approval of the biotech’s Covid-19 vaccine for emergency use. The stock is up over 600% year to date.
Lennar (NYSE:LEN) stock rose 3.1% after the housebuilder reported better than expected quarterly figures, helped by reining in costs while benefiting from a strong housing market.
Novavax (NASDAQ:NVAX) stock rose 4.1% after the EU has reached a preliminary deal to buy up to 200 million doses of its Covid-19 vaccine candidate.
General Mills (NYSE:GIS) stock rose 0.1% after the food retailer reported quarterly results ahead of expectations helped by consumers buying more of its cereals while remaining at home.
Accenture (NYSE:ACN) stock rose 6.3% after the consulting firm reported a strong first quarter and raised its full-year forecast, with demand for digital and cloud services remaining strong.
Rite Aid (NYSE:RAD) stock soared 21% after reporting an unexpected profit, driven by growth in both the retail pharmacy and pharmacy services.
- Roku (NASDAQ:ROKU) stock rose 6.6% after it resolved a long-running dispute with AT&T (NYSE:T) unit HBO Max over running the latter's content on its streaming devices. The news was followed by a number brokerage upgrades. It means HBO Max will run on its devices from Thursday.